Test Price
2,800 AED✅ Home Collection Available
PDE10A Gene Dyskinesia (Limb and Orofacial, Infantile-Onset) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين PDE10A لاضطراب الحركة الطفولي في الأطراف والفم والوجه في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
ملخص تنفيذي: يقدم تحليل جين PDE10A بتقنية التسلسل الجيني المتقدم (NGS) دقة تشخيصية تصل إلى 99.9% وفقاً لإرشادات هيئة الصحة بدبي لعام 2026، مع خدمة سحب منزلي متميزة واستشارة طبية هاتفية بعد النتيجة.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview: Early Genetic Diagnosis for Infantile-Onset Movement Disorder
The PDE10A gene test screens for pathogenic variants causing severe infantile-onset limb and orofacial dyskinesia. This next-generation sequencing test enables precise diagnosis and informs targeted management strategies. (يقوم فحص جين PDE10A بالكشف عن الطفرات المسببة لاضطراب الحركة الشديد الذي يبدأ في مرحلة الرضاعة، مما يتيح تشخيصاً دقيقاً وخطط علاجية موجهة.)
| Feature | Our UAE Test | Common Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage | Single‑gene Sanger sequencing or limited panel |
| Turnaround Time | 3 to 4 Weeks (expedited available) | 6–8 Weeks or longer |
| Diagnostic Precision | >99.9% analytical sensitivity & specificity | Variable; may miss rare variants |
| Regulatory Compliance | DHA & MOHAP approved, ISO 9001:2015 | May lack UAE-specific licensing |
Pre‑Test Preparation & Genetic Counseling
A detailed clinical history of the patient is required before sample collection. All patients must attend a genetic counselling session to draw a pedigree chart of family members affected with PDE10A‑related dyskinesia. This ensures accurate variant interpretation and meaningful results.
Acceptable Samples: Blood, Extracted DNA, or One Drop of Blood on an FTA Card. DNA FTA Card transport is available for distant patients.
Physician Insight & Safety Protocol
As a neurologist who has walked alongside many families navigating infantile movement disorders, I know how overwhelming the search for answers can be. This PDE10A gene test consistently provides the clarity needed to move forward, but it must always be correlated with a full clinical evaluation by your treating physician. Please remember, never stop any current medication without your doctor’s guidance.
— Dr. Prabhakar Reddy, DHA License 61713011, Specialist Neurologist
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Patient Safety & Exclusion Criteria
- Patients who received a blood transfusion within the last 7 days – donor DNA may interfere; reschedule sample collection after clearance.
- Severe acute febrile illness or systemic infection – postpone draw until clinical stability to avoid compromised sample quality.
Emergency Red Flags (Call 998 or visit ER immediately)
- Sudden onset of seizures, breathing difficulty, or loss of consciousness.
- Rapid worsening of dyskinesia leading to inability to feed, swallow, or protect airway.
Patient FAQ & Clinical Guidance
1. What exactly does the PDE10A gene test detect, and why is it important for my child?
This NGS test identifies disease-causing variants in the PDE10A gene linked to severe infantile-onset limb and orofacial dyskinesia, enabling a definitive diagnosis and guiding targeted clinical management.
يكشف هذا الفحص الجيني عن الطفرات المرضية في جين PDE10A المرتبطة باضطراب الحركة الشديد الذي يبدأ في مرحلة الرضاعة، مما يتيح تشخيصاً قاطعاً ويوجه الإدارة السريرية المتخصصة.
2. How is the sample collected, and is home service available in the UAE?
A trained phlebotomist performs a simple blood draw using a cold‑chain kit, and VIP home collection is available across all Emirates from 8 AM to 11 PM, including weekends.
يقوم فني مختص بسحب عينة دم بسيطة باستخدام حقيبة تبريد طبية، وتتوفر خدمة السحب المنزلي المتميزة في جميع الإمارات من الساعة 8 صباحاً حتى 11 مساءً، بما في ذلك عطلات نهاية الأسبوع.
3. Will my insurance cover the cost of this genetic test?
Many UAE insurers cover clinically indicated genetic testing; our team verifies your policy directly via WhatsApp at +971545488731 and assists with pre‑approval documents.
تغطي العديد من شركات التأمين في الإمارات الفحوصات الجينية الموصى بها طبياً؛ ويتولى فريقنا التحقق المباشر من بوليصة التأمين عبر الواتساب على الرقم +971545488731 والمساعدة في وثائق الموافقة المسبقة.
Facility License: 9834453 | ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
Compliant with Federal Decree-Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minors), and UAE PDPL for Data Privacy.
All results require correlation with clinical findings and genetic counselling.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians